DALUPHAR
ActiveSummary
The computed 12-month bankruptcy probability of DALUPHAR is 1.8% (moderate). The 2025 annual accounts show equity of €74,439 and a net result of -€30,135. Equity is shrinking by about 5.6% per year across the filed financial years. Its solvency ranks better than 22% of 5,004 sector peers (NACE 47, financial year 2025). The company has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals.
Group and network
Connections & network
1 connected companyThe connected companies are in the list below.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
ERC PHARMA ALPHA
Shared corporate director
→